Table 4

Results of Cox’s multivariate analysis for BCRS and RFS

Category (variable)β (SE)Relative risk (95% CI)aP
BCRS
 Stage<0.0001
  IReference
  II0.88 (0.41)2.41 (1.08–5.39)0.0323
  III2.25 (0.45)9.45 (3.92–22.77)<0.0001
 ER status
  Negative0.87 (0.41)2.39 (1.08–5.32)0.0321
  PositiveReference
RFS
 Stage0.0001
  IReference
  II0.56 (0.29)1.74 (0.99–3.08)0.0560
  III1.53 (0.36)4.60 (2.26–9.37)<0.0001
 Nuclear AP-2
  Low < 80%0.54 (0.25)1.71 (1.06–2.78)0.0292
  High ≥ 80%Reference
RFS in the lymph node-positive patients
 Stage
  IIReference
  III0.78 (0.31)2.17 (1.19–3.95)0.0110
 Nuclear AP-2
  Low < 80%0.79 (0.32)2.20 (1.16–4.14)0.0151
  High ≥ 80%Reference
  • a CI, confidence interval.